Entrinsic Bioscience Announces Tool with Potential for Development of New Therapies Addressing Constipation
Entrinsic Bioscience announces a tool to measure intestinal peristalsis that could lead to the development of therapeutic agents for constipation, including Irritable Bowel Syndrome-Constipation (IBS-C).
Oragenics Extends Collaboration To Develop Vaccines Against Future Variants of Coronaviruses
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced it has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) that enables Oragenics to pursue an intranasal vaccine designed to protect against future variants of coronaviruses.
LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of Ngs for High-Throughput Genotyping Market in AgBio
LGC has announced the acquisition of UF startup Rapid Genomics, a provider of mid- to high-density Next-Generation Sequencing (NGS) kits and services for genotyping in the agrigenomics market.
Exactech Announces New Patent, Strengthening Company’s Position in Joint Replacement Soft Tissue Management
UF startup Exactech, announces new patent or the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on Its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
Oragenics, Inc., announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine
Scientists and Farmers See Ways To Make AI Useful to Agriculture
In a groundbreaking, first-of-its kind event, university scientists, engineers, producers, government agencies and industry officials from throughout the South met at Auburn University to brainstorm ways to use artificial intelligence to help farmers.
World Glaucoma Week: A Retina Specialist’s Guide to Recent Innovations in Glaucoma
Ophthalmologists and researchers have made great strides in the management of glaucoma. From implants and robotics to proper administration of eye drops, glaucoma is treated more effectively than ever. This article highlights some of the latest discoveries in glaucoma, including work by UF startup and Sid Martin Biotech company TearClear.
Medication Safety 2.0: Advances in Adherence Technology
A recently published review on emerging smart technology innovations in the health care sector suggests various advanced technologies and methods may now significantly improve medication adherence.1 Two significant advances have been the ability to measure medication adherence and safety issues with medication event monitoring systems (MEMS) and smart blister packs containing radio frequency identification technology.
National Academy of Engineering Selects Professor Michele Manuel for Highest Professional Honor
The National Academy of Engineering has elected UF professor Michele Manuel, Ph.D., to join the organization’s ranks, among the highest professional honors in engineering for those who have distinguished themselves in academia, private industry, or government agencies.
Lacerta Therapeutics Expands Executive Leadership Team
UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.
